Madison-based life science company Mirus Bio to be acquired for $600 million
Mirus Bio, a manufacturer of transfection regents used in gene therapies, has entered into an agreement to be acquired.
Source: biztimes.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Milliporesigma Process Solutions. Real-time updates on events, politics, business and more.